DAVESOMERAN
UNII TYF7YW7ENF

Substance Identification & Data

This profile provides standardized clinical and technical data for Davesomeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TYF7YW7ENF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2798905-80-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
TYF7YW7ENF
CAS Registry Number
2798905-80-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DAVESOMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190750
National Cancer Institute reference terminology for clinical and research data.
INN ID
12834
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Davesomeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAVESOMERAN

Common Names & Synonyms

DAVESOMERAN [INN]
DAVESOMERAN [WHO-DD]
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN B.1.1.529.4 AND B.1.1.529.5 VARIANT PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER CX-034476), INNER SALT

Technical Codes

CX-034476 OMICRON (BA.4/BA.5)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus